Innate Pharma(IPHA) - 2025 Q2 - Earnings Call Transcript
Innate Pharma (NasdaqGS:IPHA) Q2 2025 Earnings Call September 17, 2025 08:00 AM ET Company ParticipantsStéphanie Cornen - VP - IR, Communications & Commercial StrategyJonathan Dickinson - CEO & DirectorYannis Morel - EVP & COOSonia Quaratino - EVP & Chief Medical OfficerFrédéric Lombard - SVP & CFODaina Graybosch - Senior MD - Immuno-OncologyJustin Zelin - Director - BiotechnologyConference Call ParticipantsSwayampakula Ramakanth - MD & Senior Healthcare AnalystOperatorThank you. I'd now like to turn the ca ...